Company Filing History:
1 out of 870 
1 out of 5,089 
Years Active: 2011
Title: Jirina Loucka: Innovator in Pharmaceutical Composition
Introduction
Jirina Loucka is a notable inventor based in Kladno, Czech Republic. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of whooping cough. Her innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Jirina Loucka holds 1 patent related to modified adenylate cyclase toxins. This invention is designed to be deficient in CD11b/CD18 binding and is intended for use in pharmaceutical compositions aimed at treating whooping cough and providing protection against infection. The patent also includes specific fragments of adenylate cyclase that comprise the CD11b/CD18 interaction domain, which can be utilized for targeting molecules of interest to CD11b expressing cells.
Career Highlights
Throughout her career, Jirina has worked with prestigious institutions such as the Institut Pasteur and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to develop her expertise and contribute to significant advancements in her field.
Collaborations
Jirina Loucka has collaborated with esteemed colleagues, including Claude Leclerc and Mohammed El-Azami El-Idrissi. These partnerships have further enriched her research and innovation efforts.
Conclusion
Jirina Loucka is a pioneering inventor whose work in pharmaceutical compositions has the potential to impact public health significantly. Her contributions to the field exemplify the importance of innovation in addressing critical health challenges.